AADI BIOSCIENCE, INC.

Company

Whitehawk Therapeutics, Inc.

Filed

September 7, 2021

Accession Number

0001104659-21-113485

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →